Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company

Adipose-Derived Stem Cells Are More Potent Immunomodulators Than Those Derived from Bone Marrow

By BiotechDaily International staff writers
Posted on 04 Jun 2013
A recent paper revealed that stem cells derived from fat (adipose) tissue were more potent than those originating from bone marrow as modulators of the body’s immune system.

Considering that adipose tissue-derived stem cells (AT-SCs) are far more plentiful in the body than those found in bone marrow (BM-MSCs), the findings reported by investigators at the Leiden University Medical Center (The Netherlands) should prompt further research into the use of AT-SCs in personalized immunomodulatory therapy.

The investigators compared the immunomodulatory capacities of BM-MSCs and AT-MSCs derived from age-matched donors. They reported in the May 21, 2013, online edition of the journal STEM CELLS Translational Medicine that BM-MSCs and AT-MSCs shared a similar immunophenotype and capacity for in vitro multilineage differentiation.

BM-MSCs and AT-MSCs showed comparable immunomodulatory effects as they were both able to suppress proliferation of stimulated peripheral blood mononuclear cells and to inhibit differentiation of monocyte-derived immature dendritic cells. However, at equal cell numbers, the AT-MSCs showed more potent immunomodulatory effects in both assays as compared with BM-MSCs. Moreover, AT-MSCs showed a higher level of secretion of cytokines that have been implicated in the immunomodulatory modes of action of multipotent stromal cells, such as interleukin-6 and transforming growth factor-beta-1 (TGF-beta-1).

AT-MSCs displayed higher metabolic activity than BM-MSCs, which meant that lower numbers of AT-MSCs could evoke the same level of immunomodulation as higher numbers of BM-MSCs.


Drug Discovery

view channel
Image: Use of catchphrase terms like “breakthrough” and “promising” in public news media presenting new drugs tends to result in incorrect assumptions and conclusions about the meaning and significance of criteria for FDA breakthrough-designated and accelerated-approval drugs (Photo courtesy of Dartmouth Institute).

Words That Inappropriately Enhance Perception of New Drug’s Effectiveness

Researchers have found that using the words “breakthrough” and “promising” in presenting a new drug to the general public often has a dramatic effect on judgment about its effectiveness.... Read more

Lab Technologies

view channel

New Genomic Research Kit Simplifies Exome Studies

An exciting new tool is now available for biotech researchers working in the field of genomic analysis. The human exome is critical to our genetic make-up and is generally accepted as having the greatest influence on how the genetic blueprint is utilized. The exome is defined as all coding exons in the genome and is... Read more


view channel

Sale of Mexican Pharmaceutical Company Expected to Boost Latin American Prescription Drug Market

The sale of a major Mexican pharmaceutical company to an international generic drug corporation is expected to accelerate the growth of the Latin American market for prescription drugs. Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel) announced that it has entered into definitive agreements to buy Representaciones... Read more


17 Oct 2015 - 21 Oct 2015
25 Oct 2015 - 29 Oct 2015
16 Nov 2015 - 19 Nov 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.